Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 3/20 | 0.60 |
| ▸ | CA12 | O43570 | 1/20 | 0.60 |
| ▸ | CA1 | P00915 | 1/20 | 0.60 |
| ▸ | CA2 | P00918 | 1/20 | 0.60 |
| ▸ | CA3 | P07451 | 1/20 | 0.60 |
| ▸ | CA4 | P22748 | 1/20 | 0.60 |
| ▸ | CA6 | P23280 | 1/20 | 0.60 |
| ▸ | CA5A | P35218 | 1/20 | 0.60 |
| ▸ | CA7 | P43166 | 1/20 | 0.60 |
| ▸ | CA9 | Q16790 | 1/20 | 0.60 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.60 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.52 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6350350 | 0.85 | ABCG2 (0.60) | ABCB1GAAABCG2 | |
| SCHEMBL11157101 | 0.82 | PKM (0.62) | PKMCA12CA1CA2CA3 | |
| SCHEMBL16040102 | 0.81 | PKM (0.56) | PKMCA12CA1CA2CA3 | |
| SCHEMBL3751049 | 0.80 | SLC22A6 (0.66) | CYP1A2KMT2AKDM4EABCG2SNCA | |
| SCHEMBL547153 | 0.79 | CYP1A2 (0.63) | CA12CA1CA2CA4CA6 | |
| SCHEMBL30307376 | 0.79 | CYP1A2 (0.63) | CA12CA1CA2CA4CA6 | |
| SCHEMBL25311659 | 0.79 | PKM (0.53) | PKMCA12CA1CA2CA3 | |
| SCHEMBL6229897 | 0.78 | TSHR (0.64) | LMNAABCB1KMT2AALDH1A1MAPT | |
| SCHEMBL15288999 | 0.77 | PKM (0.72) | PKMCA12CA1CA2CA3 | |
| SCHEMBL27905025 | 0.77 | PKM (0.72) | PKMCA12CA1CA2CA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103958572-A | Styrene-siloxane triblock copolymers as membranes for selective transport of alcohols and other organic compounds in aqueous mixtures | UNIV CALIFORNIA | 2014-07-30 | — | — | CN | claimed |
| CN-101802107-A | Dye composition comprising at least one colourless disulfide/thiol precursor and dyeing process using said composition | OREAL | 2010-08-11 | — | — | CN | claimed |
| EP-3074484-B1 | DEPOLYMERISATION OF LIGNIN IN BIOMASS | KAT2BIZ AB (SE) | 2020-04-15 | — | — | EP | disclosed |
| US-10150790-B2 | Depolymerisation of lignin in biomass | KAT2BIZ AB (SE) | 2018-12-11 | — | — | US | disclosed |
| US-20170152278-A1 | Depolymerisation Of Lignin In Biomass | BIOLEUM IP HOLDINGS LLC | 2017-06-01 | — | — | US | disclosed |
| CN-103958572-A | Styrene-siloxane triblock copolymers as membranes for selective transport of alcohols and other organic compounds in aqueous mixtures | UNIV CALIFORNIA | 2014-07-30 | — | — | CN | disclosed |
| CN-101802107-A | Dye composition comprising at least one colourless disulfide/thiol precursor and dyeing process using said composition | OREAL | 2010-08-11 | — | — | CN | disclosed |
| CN-100413845-C | Compounds for modulating cell proliferation | HSC RES & DEV LTD (CA) | 2008-08-27 | — | — | CN | disclosed |
| CN-1633411-A | Compounds for modulating cell proliferation | HOSPITAL FOR SICK CHILDREN (CA) | 2005-06-29 | — | — | CN | disclosed |
| CN-1429202-A | Compounds for modulating cell proliferation | HSC RES & DEV LTD PARTNERSHIP (CA) | 2003-07-09 | — | — | CN | disclosed |
| CN-1376660-A | Synthesis of substituted trans-cinnamic aldehyde-natural yellow dyestuff from phenylpropyl alkyl derivatives | COUNCIL SCIENT IND RES (IN) | 2002-10-30 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170152278-A1 | Depolymerisation Of Lignin In Biomass | DCXR, LCT, MGAM | PKM 1999/4885CA12 1035/4885CA1 2051/4885 |
| US-10150790-B2 | Depolymerisation of lignin in biomass | DCXR, LCT, MGAM | PKM 1999/4885CA12 1035/4885CA1 2051/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.